Frontlight ResearchEarly access
Trial site
Malopolskie Centrum Alergologii Sp. z o.o.
- 5running trials
- 6closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Asthma10 trials
- Chronic spontaneous urticaria1 trial
- Phase
- Phase 37 trials
- Phase 24 trials
- Status
- Completed6 trials
- Active, not recruiting3 trials
- Recruiting2 trials
- Lead sponsor
- Chiesi Farmaceutici S.p.A.2 trials
- Upstream Bio Inc.2 trials
- Astrazeneca AB1 trial
- Celldex Therapeutics1 trial
- GlaxoSmithKline1 trial
- and 4 more
Running trials
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Asthma2 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 15 Nov 2026